BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17230066)

  • 1. Early lymphocyte recovery as a prognostic indicator for high-risk Ewing sarcoma.
    De Angulo G; Hernandez M; Morales-Arias J; Herzog CE; Anderson P; Wolff J; Kleinerman ES
    J Pediatr Hematol Oncol; 2007 Jan; 29(1):48-52. PubMed ID: 17230066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of early lymphocyte recovery in pediatric osteosarcoma.
    Moore C; Eslin D; Levy A; Roberson J; Giusti V; Sutphin R
    Pediatr Blood Cancer; 2010 Dec; 55(6):1096-102. PubMed ID: 20734401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies.
    De Angulo G; Yuen C; Palla SL; Anderson PM; Zweidler-McKay PA
    Cancer; 2008 Jan; 112(2):407-15. PubMed ID: 18058809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma.
    Shankar AG; Ashley S; Craft AW; Pinkerton CR
    Med Pediatr Oncol; 2003 Mar; 40(3):141-7. PubMed ID: 12518341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
    Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte recovery as a positive predictor of prolonged survival after autologous peripheral blood stem cell transplantation in T-cell non-Hodgkin's lymphoma.
    Kim H; Sohn HJ; Kim SE; Kang HJ; Park S; Kim S; Kim WK; Lee JS; Suh C
    Bone Marrow Transplant; 2004 Jul; 34(1):43-9. PubMed ID: 15107814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term review of the treatment of patients with Ewing's sarcoma in one institution.
    Sluga M; Windhager R; Lang S; Heinzl H; Krepler P; Mittermayer F; Dominkus M; Zoubek A; Kotz R
    Eur J Surg Oncol; 2001 Sep; 27(6):569-73. PubMed ID: 11520091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis.
    Porrata LF; Gertz MA; Litzow MR; Lacy MQ; Dispenzieri A; Inwards DJ; Ansell SM; Micallef IN; Gastineau DA; Elliott M; Hogan WJ; Hayman SR; Tefferi A; Markovic SN
    Clin Cancer Res; 2005 Feb; 11(3):1210-8. PubMed ID: 15709191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer.
    Porrata LF; Ingle JN; Litzow MR; Geyer S; Markovic SN
    Bone Marrow Transplant; 2001 Nov; 28(9):865-71. PubMed ID: 11781647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.
    Porrata LF; Ristow K; Habermann TM; Witzig TE; Inwards DJ; Markovic SN
    Am J Hematol; 2009 Feb; 84(2):93-7. PubMed ID: 19123458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraskeletal Ewing's sarcoma.
    Ahmad R; Mayol BR; Davis M; Rougraff BT
    Cancer; 1999 Feb; 85(3):725-31. PubMed ID: 10091746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma.
    Porrata LF; Litzow MR; Inwards DJ; Gastineau DA; Moore SB; Pineda AA; Bundy KL; Padley DJ; Persky D; Ansell SM; Micallef IN; Markovic SN
    Bone Marrow Transplant; 2004 Feb; 33(3):291-8. PubMed ID: 14676784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis and Ewing sarcoma--relationship to pulmonary metastasis and survival.
    Mikulić D; Ilić I; Cepulić M; Giljević JS; Orlić D; Zupancić B; Fattorini I; Seiwerth S
    J Pediatr Surg; 2006 Mar; 41(3):524-9. PubMed ID: 16516628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soft-tissue Ewing sarcoma in a low-incidence population: comparison to skeletal Ewing sarcoma for clinical characteristics and treatment outcome.
    Lee JA; Kim DH; Lim JS; Koh JS; Kim MS; Kong CB; Song WS; Cho WH; Lee SY; Jeon DG
    Jpn J Clin Oncol; 2010 Nov; 40(11):1060-7. PubMed ID: 20513751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry.
    Lee J; Hoang BH; Ziogas A; Zell JA
    Cancer; 2010 Apr; 116(8):1964-73. PubMed ID: 20151425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term results following multidisciplinary treatment of localized Ewing's sarcoma in children and adolescents].
    Ullmann C; Beck JD; Holter W; Petsch S; Dunst J; Sauer R; Grabenbauer GG
    Strahlenther Onkol; 2008 Mar; 184(3):137-44. PubMed ID: 18330509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia.
    Behl D; Porrata LF; Markovic SN; Letendre L; Pruthi RK; Hook CC; Tefferi A; Elliot MA; Kaufmann SH; Mesa RA; Litzow MR
    Leukemia; 2006 Jan; 20(1):29-34. PubMed ID: 16281063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment results of the Ewing sarcoma of bone and prognostic factors.
    Sari N; Toğral G; Cetindağ MF; Güngör BS; Ilhan IE
    Pediatr Blood Cancer; 2010 Jan; 54(1):19-24. PubMed ID: 19760772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES).
    Haeusler J; Ranft A; Boelling T; Gosheger G; Braun-Munzinger G; Vieth V; Burdach S; van den Berg H; Juergens H; Dirksen U
    Cancer; 2010 Jan; 116(2):443-50. PubMed ID: 19924786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The European experience with megadose therapy and autologous bone marrow transplantation in solid tumors with poor prognosis Ewing sarcoma, germ cell tumors and brain tumors)].
    Ladenstein R; Gadner H; Hartmann O; Pico J; Biron P; Thierry P
    Wien Med Wochenschr; 1995; 145(2-3):55-7. PubMed ID: 7762255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.